Global HDAC (Histone Deacetylase) Inhibitors Market 2022-2026

Global HDAC (Histone Deacetylase) Inhibitors Market 2022-2026

Technavio has been monitoring the HDAC (histone deacetylase) inhibitors market and it is poised to grow by $ 162.42 mn during 2022-2026, decelerating at a CAGR of 7.40% during the forecast period. Our report on the HDAC (histone deacetylase) inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by high target affinity and specificity and the high prevalence of oncology indications.

The HDAC (histone deacetylase) inhibitors market analysis includes the route of administration segment and geographic landscape.

Technavio's HDAC (histone deacetylase) inhibitors market is segmented as below:

By Route of Administration

  • Oral HDAC inhibitors
  • Parenteral HDAC inhibitors
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the development of novel drug delivery systems and combination therapiesas one of the prime reasons driving the HDAC (histone deacetylase) inhibitors market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on HDAC (histone deacetylase) inhibitors market covers the following areas:
  • HDAC (histone deacetylase) inhibitors market sizing
  • HDAC (histone deacetylase) inhibitors market forecast
  • HDAC (histone deacetylase) inhibitors market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading HDAC (histone deacetylase) inhibitors market vendors that include Bristol Myers Squibb Co., Eisai Co. Ltd., GNT Biotech and Medicals Corp., Huya Bioscience International LLC, Italfarmaco Spa, Merck and Co. Inc., Novartis AG, Onxeo SA, Shenzhen Chipscreen Biosciences Co. Ltd., and Spectrum Pharmaceuticals Inc. Also, the HDAC (histone deacetylase) inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Companies Mentioned

Bristol Myers Squibb Co., Eisai Co. Ltd., GNT Biotech and Medicals Corp., Huya Bioscience International LLC, Italfarmaco Spa, Merck and Co. Inc., Novartis AG, Onxeo SA, Shenzhen Chipscreen Biosciences Co. Ltd., Spectrum Pharmaceuticals Inc.


  • Executive Summary
  • Market Landscape
    • Market ecosystem
      • Parent market
        • Table Parent market
        • Table Market characteristics
    • Value chain analysis
      • Table Value chain analysis: Pharmaceuticals
      • Research and development (R&D) and drug discovery
      • Integration and product development
      • Manufacturing
      • Outbound logistics
      • Marketing and sales
      • Support services
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2021
    • Market outlook: Forecast for 2021 - 2026
      • Table Global - Market size and forecast 2021 - 2026 ($ million)
      • Table Global market: Year-over-year growth 2021 - 2026 (%)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis 2021 & 2026
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2021
  • Market Segmentation by Route of administration
    • Market segments
      • Table Route of administration - Market share 2021-2026 (%)
    • Comparison by Route of administration
      • Table Comparison by Route of administration
    • Oral HDAC inhibitors - Market size and forecast 2021- 2026
      • Table Oral HDAC inhibitors - Market size and forecast 2021-2026 ($ million)
      • Table Oral HDAC inhibitors - Year-over-year growth 2021-2026 (%)
      • Table Oral HDAC inhibitors: Pipeline overview
    • Parenteral HDAC inhibitors - Market size and forecast 2021-2026
      • Table Parenteral HDAC inhibitors - Market size and forecast 2021-2026 ($ million)
      • Table Parenteral HDAC inhibitors - Year-over-year growth 2021-2026 (%)
    • Market opportunity by Route of administration
      • Table Market opportunity by Route of administration
  • Customer landscape
    • Table Customer landscape
  • Geographic Landscape
    • Geographic segmentation
      • Table Market share by geography 2021-2026 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2021-2026
      • Table North America - Market size and forecast 2021-2026 ($ million)
      • Table North America - Year-over-year growth 2021-2026 (%)
    • Europe - Market size and forecast 2021-2026
      • Table Europe - Market size and forecast 2021-2026 ($ million)
      • Table Europe - Year-over-year growth 2021-2026 (%)
    • Asia - Market size and forecast 2021-2026
      • Table Asia - Market size and forecast 2021-2026 ($ million)
      • Table Asia - Year-over-year growth 2021-2026 (%)
    • ROW - Market size and forecast 2021-2026
      • Table ROW - Market size and forecast 2021-2026 ($ million)
      • Table ROW - Year-over-year growth 2021-2026 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • High target affinity and specificity
      • High prevalence of oncology indications
        • Table Prevalence of top 5 cancers newly reported in US 2019
      • Development of novel drug delivery systems and combination therapies
        • Table Pipeline of combination therapies - Syndax
    • Market challenges
      • High costs associated with treatment
        • Table Treatment costs of HDAC inhibitors
      • Preference for alternative treatments
        • Table Alternative treatment options for oncology conditions
      • Adverse effects
        • Table Side effects of HDAC
        • Table Impact of drivers and challenges
    • Market trends
      • Strategic alliances
        • Table Some strategic alliances in the global HDAC inhibitors market
      • Extension of research areas
        • Table drugs with respect to their cancer indications and expanded indications
      • Increasing awareness about cancer
  • Vendor Landscape
    • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
      • Table Industry risks
    • Competitive landscape
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bristol Myers Squibb Co.
      • Table Bristol Myers Squibb Co. - Overview
      • Table Bristol Myers Squibb Co. - Product and service
      • Table Bristol Myers Squibb Co. - Key offerings
    • Eisai Co. Ltd.
      • Table Eisai Co. Ltd. - Overview
      • Table Eisai Co. Ltd. - Business segments
      • Table Eisai Co. Ltd. - Key offerings
      • Table Eisai Co. Ltd. - Segment focus
    • GNT Biotech and Medicals Corp.
      • Table GNT Biotech and Medicals Corp. - Overview
      • Table GNT Biotech and Medicals Corp. - Product and service
      • Table GNT Biotech and Medicals Corp. - Key offerings
    • Huya Bioscience International LLC
      • Table Huya Bioscience International LLC - Overview
      • Table Huya Bioscience International LLC - Product and service
      • Table Huya Bioscience International LLC - Key offerings
    • Italfarmaco Spa
      • Table Italfarmaco Spa - Overview
      • Table Italfarmaco Spa - Product and service
      • Table Italfarmaco Spa - Key offerings
    • Merck and Co. Inc.
      • Table Merck and Co. Inc. - Overview
      • Table Merck and Co. Inc. - Business segments
      • Table Merck and Co. Inc. - Key offerings
      • Table Merck and Co. Inc. –Key news
      • Table Merck and Co. Inc. - Segment focus
    • Novartis AG
      • Table Novartis AG - Overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Key news
      • Table Novartis AG - Segment focus
    • Onxeo SA
      • Table Onxeo SA - Overview
      • Table Onxeo SA - Business segments
      • Table Onxeo SA - Key offerings
      • Table Onxeo SA - Segment focus
    • Shenzhen Chipscreen Biosciences Co. Ltd.
      • Table Shenzhen Chipscreen Biosciences Co. Ltd. - Overview
      • Table Shenzhen Chipscreen Biosciences Co. Ltd. - Product and service
      • Table Shenzhen Chipscreen Biosciences Co. Ltd. - Key offerings
    • Spectrum Pharmaceuticals Inc.
      • Table Spectrum Pharmaceuticals Inc. - Overview
      • Table Spectrum Pharmaceuticals Inc. - Product and service
      • Table Spectrum Pharmaceuticals Inc. - Key offerings
  • Appendix
    • Scope of the report
      • Market definition
      • Objective
      • Notes and caveats
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research Methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings